YOLFTbeta
DexCom Inc

DexCom Inc

DXCM · NASDAQ · Healthcare / Medical Devices

83.33USD+1.94 (+2.38%)

Price History

Full chart

Market Stats

Previous Close81.39
Open82.01
Day Range81.39 – 83.66
52-Week Range54.11 – 92.59
Volume3.01M
Market Cap30.29B
P/E (TTM)34.01
Forward P/E28.25
EPS2.36
Dividend Yield0.00%
Beta1.48
50-Day Avg87.53
200-Day Avg74.16

About

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Jacob Steven Leach
  • Employees11.00K
  • Headquarters6340 Sequence Drive, San Diego, CA, United States, 92121, USA
  • Websitehttps://www.dexcom.com

Leadership

  • Mr. Kevin Ronald SayerExecutive Chairman of the Board · b. 1958
  • Mr. Jacob Steven LeachPresident, CEO & Director · b. 1978
  • Mr. Jereme M. Sylvain CPAExecutive VP, CFO, COO & Chief Accounting Officer · b. 1980
  • Mr. Michael Jon Brown J.D.Executive VP, Chief Legal & Compliance Officer · b. 1970
  • Ms. Sadie M. SternExecutive VP, Chief People & Culture Officer · b. 1975
  • Mr. Jon ColemanExecutive VP & Chief Commercial Officer · b. 1964
  • Mr. Peter SimpsonExecutive VP & CTO
  • Mr. Sean ChristensenVice President of Finance and Investor Relations
  • Mr. Matthew DolanExecutive Vice President of Strategy & Corporate Development · b. 1981
  • Keri LeoneSenior Director of Global Medical Science & Education

Financials

Income Statement

Currency: USD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue------2.17M4.63M9.84M29.69M48.63M76.27M99.90M160.00M259.20M402.00M573.30M718.50M1.03B1.48B1.93B2.45B2.91B3.62B4.03B4.66B
Growth (%)-------+113.25%+112.62%+201.82%+63.78%+56.83%+30.99%+60.16%+62.00%+55.09%+42.61%+25.33%+43.58%+43.08%+30.54%+27.08%+18.84%+24.49%+11.34%+15.60%
Cost of Revenue------10.96M12.74M15.37M26.03M30.19M40.42M53.30M59.90M82.90M123.60M194.90M226.40M367.70M544.50M646.60M768.00M1.03B1.33B1.59B1.86B
Gross Profit-------8.79M-8.11M-5.53M3.66M18.44M35.84M46.60M100.10M176.30M278.40M378.40M492.10M663.90M931.50M1.28B1.68B1.88B2.29B2.44B2.80B
Gross Margin-------405.07%-175.25%-56.20%12.33%37.92%47.00%46.65%62.56%68.02%69.25%66.00%68.49%64.36%63.11%66.44%68.63%64.72%63.19%60.46%60.10%
Operating Expense------40.53M38.57M47.30M49.49M63.73M80.69M102.30M129.00M197.80M335.50M442.30M534.60M850.20M789.20M980.60M1.41B1.49B1.69B1.84B1.89B
Operating Income-4.01M-6.72M-6.31M-10.18M-14.07M-32.43M-49.32M-46.68M-52.83M-45.83M-45.29M-44.84M-55.70M-28.90M-21.50M-57.10M-63.90M-42.50M-186.30M142.30M299.50M265.80M391.20M597.70M600.00M911.80M
Operating Margin-------2273.03%-1008.77%-536.97%-154.36%-93.13%-58.80%-55.76%-18.06%-8.29%-14.20%-11.15%-5.92%-18.06%9.64%15.54%10.86%13.44%16.50%14.88%19.56%
EBITDA-4.01M-6.72M-6.31M-9.83M-13.13M-29.70M-46.62M-43.34M-49.79M-43.11M-51.19M-40.98M-49.00M-21.90M-13.10M-46.30M-49.20M-19.70M-74.70M213.20M376.80M377.60M565.30M916.70M945.70M1.36B
EBITDA Margin-------2148.69%-936.76%-506.11%-145.17%-105.25%-53.73%-49.05%-13.69%-5.05%-11.52%-8.58%-2.74%-7.24%14.44%19.56%15.42%19.43%25.31%23.45%29.14%
Net Income-3.96M-6.27M-7.71M-9.91M-13.95M-30.77M-46.60M-45.88M-55.18M-53.52M-55.17M-44.75M-54.50M-29.80M-22.40M-57.60M-65.60M-50.20M-127.10M101.10M493.60M216.90M341.20M541.50M576.20M836.30M
Net Income Margin-------2147.64%-991.53%-560.93%-180.26%-113.45%-58.67%-54.55%-18.63%-8.64%-14.33%-11.44%-6.99%-12.32%6.85%25.62%8.86%11.73%14.95%14.29%17.94%
R&D2.90M5.04M6.31M8.93M12.47M26.77M19.42M16.13M19.63M14.29M23.23M30.75M39.50M44.80M69.40M137.50M156.10M185.40M417.40M273.50M359.90M604.20M484.20M505.80M552.40M599.10M
R&D as % of Total Revenue------895.00%348.63%199.52%48.14%47.76%40.32%39.54%28.00%26.77%34.20%27.23%25.80%40.46%18.53%18.68%24.68%16.64%13.96%13.70%12.85%
Interest Expense000000007.28M8.04M1.55M11.00K200.00K900.00K800.00K400.00K700.00K12.80M22.70M60.30M84.70M18.80M18.60M20.30M19.00M18.30M
Interest Expense % of Total Revenue------0.00%0.00%74.03%27.09%3.18%0.01%0.20%0.56%0.31%0.10%0.12%1.78%2.20%4.09%4.40%0.77%0.64%0.56%0.47%0.39%

Balance Sheet

Currency: USD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets14.36M8.64M-20.77M29.36M56.73M64.55M77.26M44.37M46.95M77.16M120.47M106.00M122.50M184.60M292.00M402.80M904.10M1.92B2.40B4.29B4.93B5.39B6.26B6.48B6.34B
Total Liabilities---53.37M78.67M7.31M7.72M70.14M82.98M65.39M16.17M15.98M29.00M38.40M44.40M70.80M119.00M484.70M1.25B1.51B2.46B2.89B3.26B4.20B4.38B3.59B
Total Equity-3.19M-8.93M--32.60M-49.31M49.41M56.83M7.12M-19.47M-18.45M60.99M104.50M77.00M84.10M140.20M221.20M283.80M419.40M663.30M882.60M1.83B2.04B2.13B2.07B2.10B2.75B
Cash13.90M7.78M-20.02M27.23M37.25M18.17M23.11M12.70M3.58M4.89M2.55M8.10M43.20M71.80M86.10M94.50M441.50M1.14B446.20M817.60M1.05B642.30M566.30M606.10M917.70M
Total Debt------3.03M62.41M43.73M46.66M525.00K-7.00M6.80M4.60M2.30M45.10M361.00M1.02B1.16B1.84B2.16B2.15B2.59B2.59B1.39B
Net Debt-13.90M-7.78M--20.02M-27.23M-37.25M-15.14M39.29M31.03M43.08M-4.36M-2.60M-1.10M-36.40M-67.20M-83.80M-88.50M-113.90M-126.70M713.90M1.02B1.11B1.50B2.03B1.98B472.00M

Cash Flow

Currency: USD2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-9.46M-12.43M-22.55M-43.73M-33.21M-37.45M-39.39M-42.68M-30.13M-33.10M2.40M23.60M49.00M56.20M92.00M123.20M314.50M475.60M442.50M669.50M748.50M989.50M1.44B
Investing Cash Flow7.37M-1.74M-18.17M-26.56M-8.44M24.32M-14.10M-25.61M-46.37M28.40M20.90M-16.80M-51.50M-55.90M-144.40M-139.80M-1.02B-1.02B-216.10M-521.50M-507.20M-207.50M536.00M
Financing Cash Flow33.44K21.38M50.74M51.21M46.60M2.71M44.38M69.65M74.18M10.20M11.80M21.80M16.80M8.10M399.10M710.40M10.70M912.10M10.40M-552.50M-318.60M-734.80M-1.69B
Capital Expenditure408.61K1.76M4.68M3.35M3.44M2.49M2.99M6.86M8.01M9.50M7.90M16.20M33.30M55.70M66.00M67.10M180.00M199.00M389.20M364.80M236.60M358.80M363.50M
Free Cash Flow-9.87M-14.19M-27.23M-47.09M-36.65M-39.94M-42.38M-49.54M-38.13M-42.60M-5.50M7.40M15.70M500.00K26.00M56.10M134.50M276.60M53.30M304.70M511.90M630.70M1.08B
Dividends Paid--------0000000-----1.23B--
FCF to OCF104.32%114.14%120.74%107.66%110.37%106.65%107.60%116.07%126.58%128.70%-229.17%31.36%32.04%0.89%28.26%45.54%42.77%58.16%12.05%45.51%68.39%63.74%74.77%
Dividend Paid to FCF--------0.00%0.00%0.00%0.00%0.00%0.00%0.00%-----240.40%--

Earnings

Report DateMay 4, 2005Aug 2, 2005Nov 1, 2005Feb 27, 2006May 15, 2006Jul 20, 2006Oct 23, 2006Feb 27, 2007May 9, 2007Jul 30, 2007Oct 30, 2007Mar 11, 2008May 8, 2008Aug 5, 2008Nov 10, 2008Mar 5, 2009May 6, 2009Aug 3, 2009Nov 4, 2009Mar 9, 2010May 5, 2010Aug 3, 2010Nov 4, 2010Mar 3, 2011May 3, 2011Aug 3, 2011Nov 2, 2011Feb 23, 2012May 2, 2012Aug 6, 2012Nov 1, 2012Feb 21, 2013May 1, 2013Aug 7, 2013Nov 6, 2013Feb 20, 2014May 1, 2014Aug 6, 2014Nov 6, 2014Feb 25, 2015Apr 29, 2015Aug 5, 2015Nov 4, 2015Feb 23, 2016Apr 27, 2016Aug 2, 2016Nov 1, 2016Feb 28, 2017May 2, 2017Aug 1, 2017Nov 1, 2017Feb 27, 2018May 2, 2018Aug 1, 2018Nov 6, 2018Feb 21, 2019May 1, 2019Jul 31, 2019Nov 6, 2019Feb 13, 2020Apr 28, 2020Jul 28, 2020Oct 27, 2020Feb 11, 2021Apr 29, 2021Jul 29, 2021Oct 28, 2021Feb 10, 2022Apr 28, 2022Jul 28, 2022Oct 27, 2022Feb 9, 2023Apr 27, 2023Jul 27, 2023Oct 26, 2023Feb 8, 2024Apr 25, 2024Jul 25, 2024Oct 24, 2024Feb 13, 2025May 1, 2025Jul 30, 2025Oct 30, 2025Feb 12, 2026Apr 30, 2026Jul 30, 2026Oct 29, 2026
EPS Estimate--0.06-0.07-0.07-0.12-0.11-0.10-0.12-0.10-0.10-0.10-0.10-0.10-0.11-0.11-0.11-0.08-0.07-0.08-0.07-0.06-0.05-0.04-0.05-0.05-0.03-0.04-0.04-0.05-0.05-0.05-0.04-0.04-0.04-0.03-0.02-0.02-0.03-0.01-0.01-0.03-0.01-0.01-0.05-0.03-0.03-0.02-0.12-0.06-0.040.01-0.09-0.04-0.020.04-0.040.010.050.180.040.090.160.230.070.110.160.210.130.190.240.280.150.230.330.430.270.390.430.500.330.440.570.650.470.610.66
EPS Actual-0.59-0.07-0.06-0.12-0.11-0.10-0.12-0.10-0.10-0.10-0.10-0.11-0.11-0.12-0.12-0.11-0.07-0.06-0.07-0.06-0.07-0.05-0.06-0.04-0.05-0.03-0.05-0.04-0.05-0.05-0.06-0.04-0.04-0.04-0.02-0.01-0.04-0.02-0.020.01-0.04-0.01-0.020.01-0.06-0.06-0.05-0.02-0.12-0.04-0.010.03-0.08-0.020.040.14-0.010.020.160.290.110.200.240.230.080.190.220.170.080.170.280.340.170.340.500.500.320.430.450.450.320.480.610.680.560.70-
Surprise--16.67%14.29%-71.43%8.33%9.09%-20.00%16.67%0.00%0.00%0.00%-10.00%-10.00%-9.09%-9.09%0.00%12.50%14.29%12.50%14.29%-16.67%0.00%-50.00%20.00%0.00%0.00%-25.00%0.00%0.00%0.00%-20.00%0.00%0.00%0.00%33.33%50.00%-100.00%33.33%-100.00%200.00%-33.33%0.00%-0.00%-20.00%-100.00%-66.67%0.00%0.00%33.33%75.00%200.00%11.11%50.00%300.00%250.00%75.00%100.00%220.00%61.11%175.00%122.22%50.00%0.00%14.29%72.73%37.50%-19.05%-38.46%-10.53%16.67%21.43%13.33%47.83%51.52%16.28%18.52%10.26%4.65%-10.00%-3.03%9.09%7.02%4.62%19.15%14.75%-
Timing-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap30.29B
Enterprise Value32.56B
Trailing P/E34.01
Forward P/E28.25
PEG Ratio1.35
Price / Sales6.09
Price / Book12.63
EPS2.36
Book Value6.95
Revenue (TTM)4.97B
Gross Profit (TTM)3.10B
EBITDA1.40B
Profit Margin20.12%
Operating Margin24.33%
Return on Equity38.49%
Return on Assets10.33%
Shares Outstanding377.36M
Shares Float376.00M
Beta1.48
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 29 analystsTarget 96.46
  • Strong Buy
    22
  • Buy
    4
  • Hold
    3

Ownership Breakdown

Institutions
106.43%
Insiders
0.26%
Retail / Other
0.00%

Top Institutional Holders

  • BlackRock Inc
    38.24M10.13%
  • Vanguard Capital Management, LLC
    25.21M6.68%
  • Vanguard Portfolio Management, LLC
    19.66M5.21%
  • State Street Corp
    18.38M4.87%
  • Amvescap Plc.
    15.29M4.05%
  • Baillie Gifford & Co Limited.
    14.80M3.92%
  • Geode Capital Management, LLC
    12.43M3.29%
  • AllianceBernstein L.P.
    11.69M3.10%
  • UBS Asset Mgmt Americas Inc
    11.26M2.98%
  • Wellington Management Company LLP
    8.53M2.26%
  • Arrowstreet Capital Limited Partnership
    6.87M1.82%
  • NORGES BANK
    6.87M1.82%
  • UBS Group AG
    6.07M1.61%
  • Amundi
    5.60M1.48%
  • Morgan Stanley - Brokerage Accounts
    5.16M1.37%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    12.26M3.25%
  • Vanguard 500 Index Investor
    9.91M2.63%
  • Vanguard MStar Mid Cap Index Instl
    8.08M2.14%
  • Invesco QQQ Trust
    7.88M2.09%
  • Vanguard Health Care Inv
    5.81M1.54%

Stock Splits

  • Jun 13, 20224:1